Status:
COMPLETED
Cognitive Therapy for Negative Symptoms and Functioning
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Alliance for Research on Schizophrenia and Depression
Conditions:
Schizophrenia
Schizoaffective Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
This clinical trial tests the effectiveness of cognitive therapy (CT) to improve outcomes in outpatients diagnosed with schizophrenia or schizoaffective disorder who manifest prominent negative sympto...
Detailed Description
This is a clinical trial to evaluate the efficacy of adjunctive cognitive behavioral therapy for negative symptoms and functioning in chronic outpatients diagnosed with schizophrenia or schizoaffectiv...
Eligibility Criteria
Inclusion
- Outpatient diagnosed with schizophrenia or schizoaffective disorder
- Prominent negative symptoms (i.e., two global subscales rated "moderate" or higher on the Scale for the Assessment of Negative Symptoms
- Proficiency in English
- Able to give informed consent
Exclusion
- Neurologic disease or damage
- Systematic medical illnesses that may compromise neurocognitive functioning (e.g., insulin dependent diabetes, heart disease)
- History of head injury or documented loss of consciousness
- Physical handicaps that would interfere with assessment procedures
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT00350883
Start Date
July 1 2006
End Date
November 1 2011
Last Update
May 3 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychopathology Resarch Unit, Department of Psychiatry, University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104